A retrospective cohort study comparing patterns of maintenance dose escalation of vedolizumab versus infliximab in a real-world clinical practice setting in the united status.
Phase of Trial: Phase IV
Latest Information Update: 12 Dec 2016
At a glance
- Drugs Infliximab (Primary) ; Vedolizumab (Primary)
- Indications Crohn's disease; Ulcerative colitis
- Focus Therapeutic Use
- 12 Dec 2016 New trial record.
- 19 Oct 2016 Results presented at the 24th United European Gastroenterology Week